BRPI0417744A8 - Método para produzir um conjugado imunogênico, e,conjugado imunogênico - Google Patents
Método para produzir um conjugado imunogênico, e,conjugado imunogênicoInfo
- Publication number
- BRPI0417744A8 BRPI0417744A8 BRPI0417744A BRPI0417744A BRPI0417744A8 BR PI0417744 A8 BRPI0417744 A8 BR PI0417744A8 BR PI0417744 A BRPI0417744 A BR PI0417744A BR PI0417744 A BRPI0417744 A BR PI0417744A BR PI0417744 A8 BRPI0417744 A8 BR PI0417744A8
- Authority
- BR
- Brazil
- Prior art keywords
- immunogenic
- conjugate
- producing
- immunogenic conjugate
- carrier
- Prior art date
Links
- 230000002163 immunogen Effects 0.000 title abstract 7
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 125000000539 amino acid group Chemical group 0.000 abstract 2
- 125000000524 functional group Chemical group 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 239000000969 carrier Substances 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 abstract 1
- 230000001900 immune effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0007—Nervous system antigens; Prions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6068—Other bacterial proteins, e.g. OMP
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
- A61K2039/627—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier characterised by the linker
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/64—Medicinal preparations containing antigens or antibodies characterised by the architecture of the carrier-antigen complex, e.g. repetition of carrier-antigen units
- A61K2039/645—Dendrimers; Multiple antigen peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US53048003P | 2003-12-17 | 2003-12-17 | |
US60/530480 | 2003-12-17 | ||
PCT/US2004/042701 WO2005058940A2 (en) | 2003-12-17 | 2004-12-17 | Immunogenic peptide carrier conjugates and methods of producing same |
Publications (4)
Publication Number | Publication Date |
---|---|
BRPI0417744A BRPI0417744A (pt) | 2007-04-10 |
BRPI0417744A8 true BRPI0417744A8 (pt) | 2017-08-08 |
BRPI0417744B1 BRPI0417744B1 (pt) | 2020-11-03 |
BRPI0417744B8 BRPI0417744B8 (pt) | 2021-05-25 |
Family
ID=34700142
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0417744A BRPI0417744B8 (pt) | 2003-12-17 | 2004-12-17 | método para produzir um conjugado imunogênico, e,conjugado imunogênico |
Country Status (28)
Country | Link |
---|---|
US (1) | US20070134762A1 (pt) |
EP (1) | EP1701968B1 (pt) |
JP (1) | JP4764830B2 (pt) |
KR (1) | KR101157694B1 (pt) |
CN (1) | CN1984676A (pt) |
AR (1) | AR046960A1 (pt) |
AU (1) | AU2004299501B2 (pt) |
BR (1) | BRPI0417744B8 (pt) |
CA (1) | CA2549132C (pt) |
CR (1) | CR8444A (pt) |
DK (1) | DK1701968T3 (pt) |
EA (2) | EA012984B1 (pt) |
EC (1) | ECSP066655A (pt) |
ES (1) | ES2546175T3 (pt) |
HK (1) | HK1091219A1 (pt) |
HU (1) | HUE026000T2 (pt) |
IL (1) | IL176006A0 (pt) |
MY (1) | MY146566A (pt) |
NO (1) | NO340432B1 (pt) |
NZ (1) | NZ548352A (pt) |
PL (1) | PL1701968T3 (pt) |
PT (1) | PT1701968E (pt) |
SG (2) | SG182163A1 (pt) |
SI (1) | SI1701968T1 (pt) |
TW (1) | TWI355390B (pt) |
UA (1) | UA93854C2 (pt) |
WO (1) | WO2005058940A2 (pt) |
ZA (1) | ZA200604957B (pt) |
Families Citing this family (75)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080050367A1 (en) | 1998-04-07 | 2008-02-28 | Guriq Basi | Humanized antibodies that recognize beta amyloid peptide |
US7964192B1 (en) | 1997-12-02 | 2011-06-21 | Janssen Alzheimer Immunotherapy | Prevention and treatment of amyloidgenic disease |
US7790856B2 (en) | 1998-04-07 | 2010-09-07 | Janssen Alzheimer Immunotherapy | Humanized antibodies that recognize beta amyloid peptide |
TWI239847B (en) | 1997-12-02 | 2005-09-21 | Elan Pharm Inc | N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease |
US7700751B2 (en) | 2000-12-06 | 2010-04-20 | Janssen Alzheimer Immunotherapy | Humanized antibodies that recognize β-amyloid peptide |
MY139983A (en) | 2002-03-12 | 2009-11-30 | Janssen Alzheimer Immunotherap | Humanized antibodies that recognize beta amyloid peptide |
DE10303974A1 (de) | 2003-01-31 | 2004-08-05 | Abbott Gmbh & Co. Kg | Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung |
CA2513722A1 (en) * | 2003-02-01 | 2004-08-19 | Neuralab Limited | Active immunization to generate antibodies to soluble a-beta |
TWI306458B (en) | 2003-05-30 | 2009-02-21 | Elan Pharma Int Ltd | Humanized antibodies that recognize beta amyloid peptide |
CA2549552A1 (en) | 2003-12-17 | 2005-06-30 | Elan Pharmaceuticals, Inc. | A.beta. immunogenic peptide carrier conjugates and methods of producing same |
GB0410220D0 (en) | 2004-05-07 | 2004-06-09 | Kirkham Lea Ann | Mutant pneumolysin proteins |
WO2006042158A2 (en) * | 2004-10-05 | 2006-04-20 | Wyeth | Methods and compositions for improving recombinant protein production |
AR052051A1 (es) | 2004-12-15 | 2007-02-28 | Neuralab Ltd | Anticuerpos ab humanizados usados en mejorar la cognicion |
GT200600031A (es) * | 2005-01-28 | 2006-08-29 | Formulacion anticuerpo anti a beta | |
SI1868645T1 (sl) | 2005-04-08 | 2012-04-30 | Wyeth Llc | Večvalentni pnevmokokni sestavek konjugata polisaharid-protein |
US7709001B2 (en) | 2005-04-08 | 2010-05-04 | Wyeth Llc | Multivalent pneumococcal polysaccharide-protein conjugate composition |
US7955605B2 (en) | 2005-04-08 | 2011-06-07 | Wyeth Llc | Multivalent pneumococcal polysaccharide-protein conjugate composition |
US20070184072A1 (en) | 2005-04-08 | 2007-08-09 | Wyeth | Multivalent pneumococcal polysaccharide-protein conjugate composition |
EP1879613B1 (en) * | 2005-05-05 | 2011-11-30 | Merck Sharp & Dohme Corp. | Peptide conjugate compositions and methods for the prevention and treatment of alzheimer's disease |
WO2006138553A2 (en) | 2005-06-17 | 2006-12-28 | Wyeth | Methods of purifying fc region containing proteins |
US9399662B2 (en) * | 2005-11-02 | 2016-07-26 | Duke University | Concurrent chemotherapy and immunotherapy |
KR101906161B1 (ko) | 2005-11-30 | 2018-10-11 | 애브비 인코포레이티드 | 아밀로이드 베타 단백질에 대한 모노클로날 항체 및 이의 용도 |
RU2442793C2 (ru) | 2005-11-30 | 2012-02-20 | Эбботт Лэборетриз | АНТИТЕЛА ПРОТИВ ГЛОБУЛОМЕРА Аβ, ИХ АНТИГЕНСВЯЗЫВАЮЩИЕ ЧАСТИ, СООТВЕТСТВУЮЩИЕ ГИБРИДОМЫ, НУКЛЕИНОВЫЕ КИСЛОТЫ, ВЕКТОРЫ, КЛЕТКИ-ХОЗЯЕВА, СПОСОБЫ ПОЛУЧЕНИЯ УКАЗАННЫХ АНТИТЕЛ, КОМПОЗИЦИИ, СОДЕРЖАЩИЕ УКАЗАННЫЕ АНТИТЕЛА, ПРИМЕНЕНИЯ УКАЗАННЫХ АНТИТЕЛ И СПОСОБЫ ИСПОЛЬЗОВАНИЯ УКАЗАННЫХ АНТИТЕЛ |
EP1996227A2 (en) * | 2006-02-24 | 2008-12-03 | CHIESI FARMACEUTICI S.p.A. | Anti-amyloid immunogenic compositions, methods and uses |
US20090136522A1 (en) * | 2006-03-24 | 2009-05-28 | Haynes Barton F | Multivalent Immunogen |
US8784810B2 (en) | 2006-04-18 | 2014-07-22 | Janssen Alzheimer Immunotherapy | Treatment of amyloidogenic diseases |
CA2659264C (en) * | 2006-08-01 | 2016-01-26 | The Scripps Research Institute | Immunoconjugates of ghrelin for use in vaccines and methods for controlling adiposity |
US8455626B2 (en) | 2006-11-30 | 2013-06-04 | Abbott Laboratories | Aβ conformer selective anti-aβ globulomer monoclonal antibodies |
US20100311767A1 (en) | 2007-02-27 | 2010-12-09 | Abbott Gmbh & Co. Kg | Method for the treatment of amyloidoses |
US8003097B2 (en) | 2007-04-18 | 2011-08-23 | Janssen Alzheimer Immunotherapy | Treatment of cerebral amyloid angiopathy |
PL2182983T3 (pl) | 2007-07-27 | 2014-10-31 | Janssen Alzheimer Immunotherap | Leczenie chorób amyloidowych z wykorzystaniem humanizowanych przeciwciał specyficznych względem Abeta |
JO3076B1 (ar) | 2007-10-17 | 2017-03-15 | Janssen Alzheimer Immunotherap | نظم العلاج المناعي المعتمد على حالة apoe |
US9345753B2 (en) | 2008-01-16 | 2016-05-24 | Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science | Vaccine for alzheimer's disease |
EP2145898A1 (en) | 2008-07-15 | 2010-01-20 | CHIESI FARMACEUTICI S.p.A. | Anti-amyloid immunogenic compositions, methods and uses |
US9067981B1 (en) | 2008-10-30 | 2015-06-30 | Janssen Sciences Ireland Uc | Hybrid amyloid-beta antibodies |
PT2445522T (pt) | 2009-06-22 | 2017-10-04 | Wyeth Llc | Composições imunogénicas de antigénios de staphylococcus aureus |
US9125951B2 (en) | 2009-06-22 | 2015-09-08 | Wyeth Llc | Compositions and methods for preparing Staphylococcus aureus serotype 5 and 8 capsular polysaccharide conjugate immunogenic compositions |
CN101671689B (zh) * | 2009-07-29 | 2013-05-01 | 中国农业科学院上海兽医研究所 | 含日本血吸虫基因的重组表达载体及其应用 |
IN2012DN00446A (pt) * | 2009-07-30 | 2015-05-15 | Pfizer Vaccines Llc | |
EP2501403A4 (en) * | 2009-11-16 | 2013-11-13 | Jackson H M Found Military Med | BACTERIAL VACCINE AGAINST GRAM POSITIVE BASED ON (POLY) GLYCEROLPHOSPHATE |
ES2684475T3 (es) | 2010-04-15 | 2018-10-03 | Abbvie Inc. | Proteínas que se unen a beta amiloide |
CA2797052A1 (en) | 2010-04-23 | 2011-10-27 | Ancora Pharmaceuticals Inc. | Synthetic oligosaccharides for staphyloccocus vaccine |
US8716469B2 (en) | 2010-04-27 | 2014-05-06 | Ancora Pharmaceuticals, Inc. | Synthetic oligosaccharides for Moraxella vaccine |
WO2011149778A1 (en) | 2010-05-26 | 2011-12-01 | Ancora Pharmaceuticals Inc. | Synthetic oligosaccharides for neisseria meningitis vaccine |
EP2596009B1 (en) | 2010-07-19 | 2017-08-23 | Yeda Research and Development Co. Ltd. | Peptides based on the transmembrane domain of a toll-like receptor (tlr) for treatment of tlr-mediated diseases |
US9062101B2 (en) | 2010-08-14 | 2015-06-23 | AbbVie Deutschland GmbH & Co. KG | Amyloid-beta binding proteins |
EP2646462B1 (en) | 2010-11-29 | 2017-04-05 | Akershus Universitetssykehus | Methods and compositions for monitoring phagocytic activity |
CN102526724B (zh) * | 2011-01-14 | 2015-07-22 | 四川大学 | 氢氧化铝凝胶-多糖复合免疫佐剂及其制备方法和用途 |
KR101670340B1 (ko) * | 2011-05-18 | 2016-10-28 | 매트리백스 인코포레이티드 | 폴리양이온을 포함하는 단백질 매트릭스 백신 조성물 |
KR101281098B1 (ko) * | 2011-06-30 | 2013-07-02 | 주식회사 녹십자 | B형 간염 바이러스 표면 항원상의 에피토프 및 이의 용도 |
EP2766384B1 (en) * | 2011-10-10 | 2016-11-23 | Yeda Research and Development Co. Ltd. | Toll-like receptor 4 (tlr-4) agonist peptides for modulating tlr-4 mediated immune response |
RU2495048C1 (ru) * | 2012-04-18 | 2013-10-10 | Андрей Валентинович Исаев | Пептид, обладающий антиатеросклеротическим действием и композиция для профилактики и лечения атеросклероза сосудов |
CN102731659B (zh) * | 2012-06-07 | 2014-05-07 | 北京交通大学 | 一种6×His-C99重组蛋白及其制备方法和应用 |
CA2871112C (en) | 2012-07-04 | 2020-05-12 | F. Hoffmann-La Roche Ag | Covalently linked antigen-antibody conjugates |
CN103497927B (zh) * | 2013-10-21 | 2016-02-10 | 深圳大学 | 表达分泌金葡菌肠毒素蛋白的重组bcg活菌菌株、活菌疫苗及其构建方法和应用 |
BR112016014945A2 (pt) * | 2014-01-03 | 2018-01-23 | F. Hoffmann-La Roche Ag | conjugado, formulação farmacêutica e uso |
KR102278979B1 (ko) | 2014-01-03 | 2021-07-19 | 에프. 호프만-라 로슈 아게 | 공유적으로 연결된 헬리카-항-헬리카 항체 접합체 및 그의 용도 |
CN105899540B (zh) | 2014-01-03 | 2020-02-07 | 豪夫迈·罗氏有限公司 | 双特异性抗-半抗原/抗-血脑屏障受体的抗体、其复合物及它们作为血脑屏障穿梭物的应用 |
US11160855B2 (en) * | 2014-01-21 | 2021-11-02 | Pfizer Inc. | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof |
KR102598038B1 (ko) * | 2014-05-07 | 2023-11-07 | 어플라이드 몰레큘라 트랜스포트 인크. | 생물학적 활성 화물의 경구 전달용 콜릭스 독소-유래 융합 분자 |
CN104059142B (zh) * | 2014-07-03 | 2016-11-23 | 江南大学 | 一种用于制备沙门氏菌交叉型抗体的免疫原的合成方法 |
US9815886B2 (en) | 2014-10-28 | 2017-11-14 | Adma Biologics, Inc. | Compositions and methods for the treatment of immunodeficiency |
KR20170095364A (ko) * | 2014-12-18 | 2017-08-22 | 비오메리으 | 합성 이중-에피토프 화합물 |
ES2571055B1 (es) * | 2016-02-15 | 2016-12-28 | Araclon Biotech, S.L. | Conjugado amiloide y usos y procedimientos del mismo |
GB201616365D0 (en) * | 2016-09-27 | 2016-11-09 | Helsingin Yliopisto | Non-genetic modification of enveloped viruses |
CN106478802B (zh) * | 2016-10-11 | 2019-08-09 | 浙江省人民医院 | TNF-α蛋白B细胞表位,含此表位的多抗原肽及应用 |
US10259865B2 (en) | 2017-03-15 | 2019-04-16 | Adma Biologics, Inc. | Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection |
CN107648618B (zh) * | 2017-09-27 | 2020-05-08 | 国家纳米科学中心 | 一种药物递送体系及其制备方法与应用 |
US11918646B2 (en) | 2017-12-11 | 2024-03-05 | Board Of Regents, The University Of Texas System | Dry adjuvanted immune stimulating compositions and use thereof for mucosal administration |
CN110018253A (zh) * | 2019-04-15 | 2019-07-16 | 艾美卫信生物药业(浙江)有限公司 | 一种生物制品中游离蛋白含量的高效液相测定方法 |
CN111499724A (zh) * | 2020-04-15 | 2020-08-07 | 上海领潮生物新材料有限公司 | 一种s-腺苷同型半胱氨酸-鸡卵白蛋白偶联物的制备方法 |
CN111896737B (zh) * | 2020-08-03 | 2023-07-07 | 北京望尔生物技术有限公司 | 一种蛇形菌素人工抗原在酶联免疫试剂盒中的应用 |
JP2024504512A (ja) | 2020-12-21 | 2024-01-31 | コーネル・ユニバーシティー | ペプチド連結薬物送達系 |
CA3221075A1 (en) * | 2021-05-28 | 2022-12-01 | Pfizer Inc. | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof |
KR20240017325A (ko) * | 2022-07-29 | 2024-02-07 | 주식회사 엘지화학 | 항원 전달용 재조합 융합 단백질 및 이의 이용 |
Family Cites Families (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4235871A (en) | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
US4902506A (en) | 1983-07-05 | 1990-02-20 | The University Of Rochester | Immunogenic conjugates |
US4673574A (en) | 1981-08-31 | 1987-06-16 | Anderson Porter W | Immunogenic conjugates |
US5360897A (en) | 1981-08-31 | 1994-11-01 | The University Of Rochester | Immunogenic conjugates of streptococcus pneumonial capsular polymer and toxin or in toxiad |
US4501728A (en) | 1983-01-06 | 1985-02-26 | Technology Unlimited, Inc. | Masking of liposomes from RES recognition |
US5126131A (en) * | 1983-01-24 | 1992-06-30 | The Johns Hopkins University | Therapeutic suppression of specific immune responses by administration of antigen-competitive conjugates. |
US5019369A (en) | 1984-10-22 | 1991-05-28 | Vestar, Inc. | Method of targeting tumors in humans |
US4666829A (en) | 1985-05-15 | 1987-05-19 | University Of California | Polypeptide marker for Alzheimer's disease and its use for diagnosis |
US5078996A (en) | 1985-08-16 | 1992-01-07 | Immunex Corporation | Activation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor |
US4837028A (en) | 1986-12-24 | 1989-06-06 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
US5229490A (en) | 1987-05-06 | 1993-07-20 | The Rockefeller University | Multiple antigen peptide system |
US5245015A (en) * | 1991-04-26 | 1993-09-14 | Tanox Biosystems, Inc. | Monoclonal antibodies which neutralize HIV-1 through reaction with a conformational epitope in vitro |
US5057540A (en) | 1987-05-29 | 1991-10-15 | Cambridge Biotech Corporation | Saponin adjuvant |
US5089603A (en) * | 1989-06-21 | 1992-02-18 | Tanox Biosystems, Inc. | Antigenic epitopes present on membrane-bound but not secreted iga |
US5785973A (en) | 1988-02-01 | 1998-07-28 | Praxis Biologics, Inc. | Synthetic peptides representing a T-cell epitope as a carrier molecule for conjugate vaccines |
US5192540A (en) | 1988-04-19 | 1993-03-09 | American Cyanamid Company | Haemophilus influenzae type b oxidized polysaccharide-outer membrane protein conjugate vaccine |
US4912094B1 (en) | 1988-06-29 | 1994-02-15 | Ribi Immunochem Research Inc. | Modified lipopolysaccharides and process of preparation |
DE68907045T2 (de) | 1989-01-17 | 1993-12-02 | Eniricerche Spa | Synthetische Peptide und deren Verwendung als allgemeine Träger für die Herstellung von immunogenischen Konjugaten, die für die Entwicklung von synthetischen Impfstoffen geeignet sind. |
IT1237764B (it) | 1989-11-10 | 1993-06-17 | Eniricerche Spa | Peptidi sintetici utili come carriers universali per la preparazione di coniugati immunogenici e loro impiego per lo sviluppo di vaccini sintetici. |
EP0600866B1 (en) | 1990-06-01 | 1997-12-03 | Chiron Corporation | Compositions and methods for identifying biologically active molecules |
US5153312A (en) | 1990-09-28 | 1992-10-06 | American Cyanamid Company | Oligosaccharide conjugate vaccines |
CA2059692C (en) * | 1991-01-28 | 2004-11-16 | Peter J. Kniskern | Pneumoccoccal polysaccharide conjugate vaccine |
IL101715A (en) | 1991-05-02 | 2005-06-19 | Amgen Inc | Recombinant dna-derived cholera toxin subunit analogs |
DE69217497T2 (de) | 1991-09-18 | 1997-06-12 | Affymax Tech Nv | Verfahren zur synthese der verschiedenen sammlungen von oligomeren |
WO1993013302A1 (de) | 1991-12-23 | 1993-07-08 | Michael Zoche | Motor mit einer vorrichtung zur entölung |
EP0911036A3 (en) * | 1992-02-11 | 2001-05-09 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Dual carrier immunogenic construct |
AU686579B2 (en) | 1992-10-01 | 1998-02-12 | Cold Spring Harbor Laboratory | Complex combinatorial chemical libraries encoded with tags |
EP0616034B1 (en) | 1993-03-05 | 2004-10-20 | Wyeth Holdings Corporation | Plasmid for production of CRM protein and diphtheria toxin |
PT735893E (pt) | 1993-09-14 | 2009-03-06 | Pharmexa Inc | Péptidos que se ligam aos alelos pan dr para aumentar a resposta imunitária |
NZ276860A (en) | 1993-11-02 | 1997-09-22 | Affymax Tech Nv | Apparatus and its use for synthesising diverse molecular products on substrates |
US5571515A (en) * | 1994-04-18 | 1996-11-05 | The Wistar Institute Of Anatomy & Biology | Compositions and methods for use of IL-12 as an adjuvant |
EP0758313A4 (en) | 1994-05-06 | 1999-09-15 | Pharmacopeia Inc | COMBINATORIAL LIBRARY OF DIHYDROBENZOPYRANES |
US5663046A (en) | 1994-06-22 | 1997-09-02 | Pharmacopeia, Inc. | Synthesis of combinatorial libraries |
US6207646B1 (en) | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
IL115933A0 (en) | 1995-11-09 | 1996-01-31 | Oramir Semiconductor Ltd | Process and apparatus for oblique beam revolution for the effective laser stripping of sidewalls |
EP0859959B1 (en) | 1995-11-10 | 2003-08-06 | ELAN CORPORATION, Plc | Peptides which enhance transport across tissues and methods of identifying and using the same |
CA2745736C (en) | 1996-10-23 | 2016-11-22 | The Trustees Of The University Of Pennsylvania | Immunotherapy and improved vaccines |
US6962984B2 (en) * | 1996-12-05 | 2005-11-08 | Nihon University | IgA nephropathy-related DNA |
DK0848011T3 (da) | 1996-12-16 | 2001-07-16 | Nederlanden Staat | Køleelement og køleanordning |
US5877220A (en) * | 1997-03-06 | 1999-03-02 | Genta, Incorporated | Amide-based oligomeric cationic lipids |
US20020086847A1 (en) * | 1997-04-09 | 2002-07-04 | Mindset Biopharmaceuticals (Usa) | Recombinant antibodies specific for beta-amyloid ends, DNA encoding and methods of use thereof |
US6113918A (en) | 1997-05-08 | 2000-09-05 | Ribi Immunochem Research, Inc. | Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors |
US7964192B1 (en) | 1997-12-02 | 2011-06-21 | Janssen Alzheimer Immunotherapy | Prevention and treatment of amyloidgenic disease |
US8119395B1 (en) | 1998-02-27 | 2012-02-21 | The Trustees Of The University Of Pennsylvania | Vaccines, immunotherapeutics and methods for using the same |
CA2264970A1 (en) * | 1998-03-10 | 1999-09-10 | American Cyanamid Company | Antigenic conjugates of conserved lipolysaccharides of gram negative bacteria |
US6645503B1 (en) * | 1998-03-10 | 2003-11-11 | Wyeth Holdings Corporation | Antigenic conjugates of conserved lipopolysaccharides of gram negative bacteria |
DK1117435T3 (da) | 1998-09-30 | 2008-03-17 | Wyeth Corp | Muteret cholera-holotoxin som adjuvans |
WO2000050077A1 (en) * | 1999-02-25 | 2000-08-31 | Smithkline Beecham Biologicals S.A. | Immunogens comprising a peptide and a carrier derived from h.influenzae protein d |
US6945135B1 (en) * | 1999-09-09 | 2005-09-20 | L. H. Thomson Company, Inc. | Bicycle stem for enlarged handlebar portions and associated methods |
US20030190322A1 (en) * | 2000-03-31 | 2003-10-09 | Peter Kaastrup | Immunostimulating properties of a fragment of tgf-beta |
US20030092145A1 (en) * | 2000-08-24 | 2003-05-15 | Vic Jira | Viral vaccine composition, process, and methods of use |
MXPA03011135A (es) | 2001-06-07 | 2004-09-08 | Wyeth Corp | Formas mutantes de holotoxina de colera como adyuvante. |
CA2449663A1 (en) | 2001-06-07 | 2002-12-12 | Wyeth Holdings Corporation | Mutant forms of cholera holotoxin as an adjuvant |
US20030135035A1 (en) * | 2001-08-09 | 2003-07-17 | Mark Shannon | Human ZZAP1 protein |
CA2466841A1 (en) * | 2001-11-21 | 2003-06-05 | New York University | Synthetic immunogenic but non-deposit-forming polypeptides and peptides homologous to amyloid .beta., prion protein, amylin, .alpha.-synuclein, or polyglutamine repeats for induction of an immune response thereto |
CN1787839B (zh) * | 2003-03-07 | 2011-09-28 | 惠氏控股公司 | 用于抗医院内感染的免疫的多糖-葡萄球菌表面粘附素载体蛋白缀合物 |
CA2549552A1 (en) * | 2003-12-17 | 2005-06-30 | Elan Pharmaceuticals, Inc. | A.beta. immunogenic peptide carrier conjugates and methods of producing same |
-
2004
- 2004-12-17 EP EP04814839.9A patent/EP1701968B1/en active Active
- 2004-12-17 ES ES04814839.9T patent/ES2546175T3/es active Active
- 2004-12-17 CN CNA2004800378024A patent/CN1984676A/zh active Pending
- 2004-12-17 MY MYPI20045203A patent/MY146566A/en unknown
- 2004-12-17 AU AU2004299501A patent/AU2004299501B2/en not_active Ceased
- 2004-12-17 DK DK04814839.9T patent/DK1701968T3/da active
- 2004-12-17 SG SG2012041109A patent/SG182163A1/en unknown
- 2004-12-17 SI SI200432252T patent/SI1701968T1/sl unknown
- 2004-12-17 CA CA2549132A patent/CA2549132C/en active Active
- 2004-12-17 UA UAA200608018A patent/UA93854C2/ru unknown
- 2004-12-17 AR ARP040104757A patent/AR046960A1/es active IP Right Grant
- 2004-12-17 EA EA200800300A patent/EA012984B1/ru unknown
- 2004-12-17 PL PL04814839T patent/PL1701968T3/pl unknown
- 2004-12-17 PT PT48148399T patent/PT1701968E/pt unknown
- 2004-12-17 BR BRPI0417744A patent/BRPI0417744B8/pt not_active IP Right Cessation
- 2004-12-17 EA EA200601169A patent/EA010060B1/ru active IP Right Revival
- 2004-12-17 NZ NZ548352A patent/NZ548352A/en not_active IP Right Cessation
- 2004-12-17 JP JP2006545540A patent/JP4764830B2/ja not_active Expired - Fee Related
- 2004-12-17 WO PCT/US2004/042701 patent/WO2005058940A2/en active Application Filing
- 2004-12-17 US US10/583,464 patent/US20070134762A1/en not_active Abandoned
- 2004-12-17 TW TW093139525A patent/TWI355390B/zh not_active IP Right Cessation
- 2004-12-17 SG SG200809163-9A patent/SG149013A1/en unknown
- 2004-12-17 KR KR1020067014273A patent/KR101157694B1/ko active IP Right Grant
- 2004-12-17 HU HUE04814839A patent/HUE026000T2/en unknown
-
2006
- 2006-05-30 IL IL176006A patent/IL176006A0/en active IP Right Grant
- 2006-06-08 CR CR8444A patent/CR8444A/es unknown
- 2006-06-09 NO NO20062687A patent/NO340432B1/no not_active IP Right Cessation
- 2006-06-15 ZA ZA2006/04957A patent/ZA200604957B/en unknown
- 2006-06-16 EC EC2006006655A patent/ECSP066655A/es unknown
- 2006-10-27 HK HK06111894.8A patent/HK1091219A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0417744A8 (pt) | Método para produzir um conjugado imunogênico, e,conjugado imunogênico | |
BRPI0417689A8 (pt) | Método para conjugar um imonógeno de peptídeo, composição, conjugado, composição imunogênica, método para induzir uma resposta imune em um indivíduo mamífero, e, uso do conjugado | |
Ohta et al. | Glycotentacles: synthesis of cyclic glycopeptides, toward a tailored blocker of influenza virus hemagglutinin | |
PE20091388A1 (es) | Moleculas y metodos para modular el componente de complemento | |
BRPI0417341A (pt) | fator ix glicopeguilado | |
PE20090145A1 (es) | Moleculas de enlace de la pro-proteina convertasa-subtilisina/quexina tipo 9 (pcsk9) | |
BRPI0614839A2 (pt) | fator vii e fator viia glicopeguilados | |
WO2014057436A3 (en) | Anticancer conjugate | |
Expert-Bezançon et al. | Physical–chemical features of non-detergent sulfobetaines active as protein-folding helpers | |
BR0306038A (pt) | Processo para preparar sondas de oligonucleotìdeos conjugados com proteìnas de albuminas | |
CA2047031A1 (en) | Peptide-polysaccharide-protein conjugate vaccines | |
BR0113439A (pt) | Processo para a manufatura de um imunógeno para vacina, derivado de maleimida de peptìdeo de ige, uso do mesmo, conjugado adequado para uso em uma vacina e composição de vacina | |
BR112022002309A2 (pt) | Conjugado e usos do mesmo | |
BR112012019992A2 (pt) | conjugados de igf-i poli (etileno glicol) | |
Dondoni et al. | Free‐Radical Thiol‐Ene and Thiol‐Yne Couplings as Click Processes for Glycoconjugation | |
TH115317B (th) | A(สูตร) อิมมูโนจีนิกเพปไทด์แคริเออร์คอนจูเกตและวิธีการผลิตสารเดียวกันนี้ | |
Kragol et al. | Synthesis of a disulfide-linked octameric peptide construct carrying three different antigenic determinants | |
KR20220160036A (ko) | 폴리뉴클레오티드-펩티드 컨쥬게이트를 포함하는 면역 유도제 및 그것을 포함하는 의약 조성물 | |
Pérez et al. | Selective N-terminal modification of peptides and proteins using acyl phosphates | |
WO2021150910A1 (en) | Peptide immunogens targeting pituitary adenylate cyclase-activating peptide (pacap) and formulations thereof for prevention and treatment of migraine | |
TH115317A (th) | Ab อิมมูโนจีนิกเพปไทด์แคริเออร์คอนจูเกตและวิธีการผลิตสารเดียวกันนี้ | |
Nicola et al. | A novel glycoconjugation method and unexpected photo-induced site-selective protein cleavage reaction | |
Kaita et al. | 2P-026 Transduction of fluctuations along internal mechanical network in molecular machines (Protein: Structure & Function, The 47th Annual Meeting of the Biophysical Society of Japan) | |
BR122019025343B8 (pt) | molécula de ácido nucleico, vetor e método para preparação de uma molécula de anticorpo | |
TH111452A (th) | วิธีของการผลิตคอนจูเกตของตัวพาของอิมมูโนจีนิกเพปไทด์ |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B25A | Requested transfer of rights approved |
Owner name: WYETH LLC (US) |
|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B25L | Entry of change of name and/or headquarter and transfer of application, patent and certificate of addition of invention: publication cancelled |
Owner name: WYETH LLC (US) |
|
B25D | Requested change of name of applicant approved |
Owner name: WYETH LLC (US) |
|
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] | ||
B12B | Appeal against refusal [chapter 12.2 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 03/11/2020, OBSERVADAS AS CONDICOES LEGAIS. |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 17/12/2004 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |
|
B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 18A ANUIDADE. |
|
B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2703 DE 25-10-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |